Dodex

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dodex

Property Description
Active ingredient Cyanocobalamin (Vitamin B12)
Form Solution for Injection
Pharmacological class Water-Soluble Vitamin / Cobalamine
General purpose Nutritional Supplement / Antianemic
Origin Synthetic compound

What Type of Medicine is Dodex and What's its Active Ingredient?

Dodex is a specific trade name for a pharmaceutical product whose active ingredient is Cyanocobalamin, which is the most widely utilized synthetic compound serving as Vitamin B12. The substance is classified within the high-level pharmacological class of Water-Soluble Vitamins, specifically known as a Cobalamine. The preparation functions as a Nutritional Supplement and an Antianemic Preparation. Unlike some common oral Vitamin B12 products, Dodex is often designated as prescription-only due to its method of administration and the necessity for professional oversight.


What Form Does Dodex Come In?

Dodex is typically prepared as a Solution for Injection, a sterile aqueous solution suitable for administration directly into the muscle (Intramuscular) or just beneath the skin (Subcutaneous). The formulation is a single-ingredient product, comprised of the active Cyanocobalamin dissolved in a water base often containing basic excipients, such as Sodium Chloride and Benzyl Alcohol. This injectable format is clinically recognized as the necessary route for patients with confirmed malabsorption disorders, ensuring systemic availability of the compound. This highlights the product's primary use for patient groups who cannot rely on dietary intake or oral supplements alone.


What is the General Purpose of Cyanocobalamin?

The overarching general purpose of providing Cyanocobalamin is to replenish essential Vitamin B12 levels to support critical bodily processes that fail in its absence. The compound's function is required for hematopoiesis, the creation of healthy red blood cells, and for the maintenance of the structural and functional integrity of the nervous system. By restoring this vital nutrient, the preparation addresses the underlying deficiency to support these two primary physiological systems.

Regulatory References

  1. Cyanocobalamin - StatPearls
  2. Cyanocobalamin Injection: MedlinePlus Drug Information

What side effects are possible with Dodex?

Possible Side Effects and Safety Information

The officially documented safety profile for parenteral Cyanocobalamin (the active ingredient in Dodex) is derived from clinical experience and post-marketing surveillance, focusing on the classification of adverse reactions and specific patient constraints.


Serious Adverse Reactions

Regulatory documents highlight the potential for serious adverse reactions, particularly those related to the Immune System and Cardiovascular System. These include life-threatening events such as anaphylactic shock and associated fatalities. Cardiovascular risks, such as pulmonary edema and congestive heart failure, have been reported, specifically occurring early in treatment. Additionally, peripheral vascular thrombosis is listed. In cases of intense treatment for severe megaloblastic anemia, risks of hypokalemia and sudden death are documented.


Other Documented Adverse Effects

Adverse effects listed across other system-organ classes include dermatological reactions like pruritus (itching) and transitory exanthema (rash). Given that the compound contains cobalt, individuals with a known allergy to cobalt may experience cobalt sensitivity reactions. Gastrointestinal effects such as mild transient diarrhea have also been reported.


Safety Considerations and Restrictions

Official labeling includes explicit contraindications and constraints. Cyanocobalamin is contraindicated in patients with early Leber's disease (hereditary optic nerve atrophy) due to the risk of severe optic atrophy. It is also contraindicated in patients with known hypersensitivity to Vitamin B12 or cobalt. For patients with impaired kidney function receiving prolonged parenteral administration, there is a noted risk of aluminum accumulation to toxic levels. Lack of therapeutic response may be due to factors such as concomitant use of medications like Chloramphenicol.

Overdose and Emergency Response

Dodex Overdose and when to seek help

The official regulatory documentation for Dodex (Cyanocobalamin injection) provides specific guidance on its overdose profile, which is largely defined by the active ingredient's chemical properties and established safety record. The information below reflects the consensus among government health authorities.

Overdose Scope

Regulatory prescribing information confirms that no overdosage has been reported with this drug. Cyanocobalamin, being a water-soluble vitamin, is officially documented as non-toxic, even following the administration of high doses. The compound is readily excreted by the body via the urine, which prevents systemic accumulation. Due to this process, specific signs, symptoms, or life-threatening physiological outcomes resulting from acute Cyanocobalamin overdose are not listed in regulatory labeling.

Emergency Response and Classification

Classification Regulatory Statement
Toxicity Classification Officially considered non-toxic; no classification for a severe overdose syndrome is provided.
Emergency Action Treatment is unlikely to be needed in case of overdosage.

The official labeling does not mandate immediate medical attention specifically for the effects of an acute Cyanocobalamin overdose because a toxic syndrome has not been reported. Consequently, no specific antidote, complex procedural steps, or specialized monitoring requirements are described by regulators for the management of an overdose of this injection. This low toxicity profile is consistent across general population statements.

Therapeutic Uses of Dodex

What Dodex Treats: Main Uses and Benefits

Dodex (a form of Vitamin B12) is used to treat conditions associated with a chronic lack of this essential nutrient, which addresses symptoms related to systemic imbalance and increased neurological activity. The treatment is applied in addressing the deficiency and provides support in managing its symptomatic effects. The injection is commonly used for people who are unable to absorb B12 from the intestine, such as those with pernicious anemia, or following stomach or intestinal surgery.

It is used for managing the physical symptoms related to systemic imbalance, including profound fatigue, weakness, numbness, and tingling. It is applied across therapeutic domains where additional symptomatic support is needed to manage these neurological issues and severe fatigue. This treatment is relevant when supportive symptom management is appropriate and contributes to easing the overall symptom load.

Quick Fact: Support in Managing Persistent Weakness

Dodex may assist with managing symptoms related to persistent weakness and fatigue by addressing the nutritional deficiency. This provides support that helps improve day-to-day comfort during symptomatic periods.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Dodex?

Dodex (Cyanocobalamin injection) eligibility is strictly defined by regulatory authorities and centers on underlying diagnosis and specific patient characteristics. This section details the official population rules.


Populations Excluded (Contraindications)

The medicine is contraindicated and must not be used in specific groups:

  • Patients with known hypersensitivity (allergy) to Cyanocobalamin (Vitamin B12) or to Cobalt.
  • Individuals diagnosed with early Leber's disease (hereditary optic nerve atrophy).

Conditional Use and Restrictions

Certain populations and conditions require special caution or restriction:

  • Pediatric Use: Use in neonates and premature infants requires caution if the specific formulation contains the excipient Benzyl Alcohol, due to toxicity risks.
  • Renal Impairment: Patients with impaired kidney function should be treated with caution due to the risk of aluminum accumulation from the injectable solution.
  • Pregnancy: Use is not recommended for megaloblastic anemia of pregnancy unless B12 deficiency is confirmed, as it may mask an underlying folate deficiency.
  • Severe Anemia: Patients with severe megaloblastic anemia require close monitoring of serum potassium during the initial treatment phase.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents detail the interaction profile for the active ingredient, Cyanocobalamin, focusing on therapeutic antagonism, absorption interference, and assay procedural constraints.

A critical pharmacodynamic interaction involves Chloramphenicol, which is documented to potentially antagonize the hematopoietic response intended by the Vitamin B12 therapy. Co-administration is noted for its potential to reduce the desired effect on blood cell production.

Several drug classes are officially listed as impacting the body’s vitamin B12 status by impairing its gastrointestinal absorption. These substances include Proton Pump Inhibitors (e.g., Omeprazole), Histamine H2-Receptor Antagonists, certain anticonvulsants (such as Phenytoin), Metformin, Colchicine, and Para-aminosalicylic acid. These interactions affect oral B12 availability, providing context for the use of the injectable form.

Procedural constraints also exist regarding laboratory testing. Antibiotics, Methotrexate, and Pyrimethamine may invalidate the microbiological assay used to measure serum levels of Vitamin B12 or Folic Acid. High doses of Vitamin C are documented to potentially destroy B12 and, if B12 is administered orally, a mandatory timing separation rule applies. Additionally, a caution exists concerning the risk of aluminum toxicity from prolonged parenteral administration in premature infants or patients with impaired kidney function.

Mechanism of Action

Cofactor Restoration and Pathway Modulation

Dodex (Cyanocobalamin) is a synthetic precursor that undergoes intracellular conversion into the two essential cofactors, methylcobalamin and 5-deoxyadenosylcobalamin. The primary mechanistic domain involves supplying these cofactors to restore the function of the enzymes Methionine Synthase (MS) and L-Methylmalonyl-CoA Mutase (MCM). The restored MS activity facilitates the recycling of tetrahydrofolate, a step required for purine and pyrimidine synthesis. It also facilitates the conversion of homocysteine into methionine. Simultaneously, the restored MCM activity promotes the conversion of methylmalonyl-CoA into succinyl-CoA. This dual-pathway modulation impacts cell proliferation and lipid metabolism.


Downstream Physiological Consequence

This cascade of restored enzymatic function translates into two major system-level consequences. The regulated DNA synthesis influences the maturation and division of rapidly proliferating cells, particularly those involved in hematopoiesis (red blood cell production). Additionally, the proper regulation of methylation and lipid processing is essential for the structure and synthesis of the myelin sheath surrounding nerve fibers in both central and peripheral nervous systems.

Dosage and Administration Information

How to Use Dodex

Dodex (Cyanocobalamin injection) is administered according to a structured regimen designed to first correct a significant deficiency and then maintain adequate vitamin B12 levels over time. The primary administration route is defined by the need to bypass the gastrointestinal tract in patients with malabsorption disorders, such as those with pernicious anemia.


Official Administration Guidelines

Usage Entity Official, Label-Based Instruction
Approved Routes Intramuscular (IM) injection or Deep Subcutaneous (SC) injection. The intravenous (IV) route should be avoided as it leads to rapid excretion.
Dosing Schedule Initial Treatment: 100 mcg daily for 6 to 7 days. The dose may be 250 to 1000 mcg on alternate days in some regimens.
Maintenance Dose Standard maintenance is 100 mcg monthly. Some regimens specify 1000 mcg monthly.
Duration For conditions like pernicious anemia, treatment is typically required for the remainder of the patient's life (lifelong therapy).
Preparation The solution must be visually inspected for particulate matter and discoloration before administration.

Procedural Context and Schedule

Therapy follows a phased dosing schedule, moving from the intensive, daily, initial treatment to a less frequent, monthly maintenance phase. Following the initial correction, the frequency pattern transitions to typically monthly administration. As an injectable medication, it is subject to the condition that the solution must be visually inspected immediately prior to use to confirm suitability for injection. These requirements define the standardized approach to using the medicine.

Recent Clinical Evidence

Dodex: Recent Clinical Evidence

Dodex is a brand name for the injectable form of cyanocobalamin, which is a synthetic version of Vitamin B12. The foundational evidence for cyanocobalamin is extensive, centering on its established role in addressing dietary deficiency and malabsorption conditions that result in low serum B12 levels.

Core Clinical Application

Clinical trials and observational studies consistently demonstrate the utility of injected cyanocobalamin in replenishing Vitamin B12 stores. This method of administration is typically utilized in patient populations who have impaired gastrointestinal absorption, such as those with pernicious anemia, a history of gastric surgery, or specific intestinal disorders. The primary objective is to normalize hematological indices and support neurological function, which may be compromised by severe deficiency.

  • Hematological Response: Research confirms that parenteral administration of cyanocobalamin is associated with a swift increase in reticulocytes (immature red blood cells), followed by the correction of megaloblastic anemia indices over several weeks.
  • Neurological Findings: Timely B12 replacement is observed to contribute to the stabilization or improvement of neurological symptoms, such as peripheral neuropathy, though the potential for full recovery may be inversely related to the duration of the deficiency.

Forms and Comparative Research

Cyanocobalamin is one of several forms of B12 used clinically. Comparative trials have investigated the relative performance of cyanocobalamin versus other B12 vitamers, like hydroxocobalamin. The evidence suggests that while both are effective in restoring B12 levels, the choice between them may depend on specific clinical context and regulatory approval for a given form.

Area of Research Key Observation (Neutral Summary)
Efficacy in Pernicious Anemia Associated with resolution of megaloblastic anemia indicators in trial populations.
Bioavailability vs. Oral Forms In patients with severe malabsorption, the injectable route achieved higher, more predictable serum B12 concentrations compared to oral supplementation in studied groups.

Ongoing clinical investigation focuses on optimizing maintenance strategies and exploring the role of B12 supplementation in other conditions where neurological or metabolic function may be impaired.

Key Studies & References Comparison of Efficacy and Safety of Parenteral vs Oral Route of Vitamin B12 Supplementation for the Treatment of Vitamin B12 Deficiency Anemia in Children: A Systematic Review

Frequently Asked Questions (FAQ)

Common questions about Dodex (FAQ)


Q: How quickly does Dodex start to work?

Official product information indicates that after an injection, the active ingredient typically reaches its highest level in the blood (peak plasma concentration) in about one hour. The injection route is also noted to be associated with reversal of the megaloblastic anemia associated with severe vitamin B12 deficiency.


Q: Is the research supporting Dodex long-term or short-term?

The evidence supporting the use of this medication is extensive. For certain chronic conditions, such as pernicious anemia, official regulatory documents state that treatment is typically required for the remainder of the patient's life, implying a foundation of long-term use.


Q: What is the expected duration of effect after taking Dodex?

The duration of effect is tied to the established dosing regimen. The official maintenance phase of treatment is typically specified as a monthly administration schedule, meaning the dosage is intended to sustain adequate vitamin levels for that period.


Q: Is Dodex approved for conditions other than its primary use?

Yes, according to the official label, the medicine is indicated for vitamin B12 deficiencies that may be associated with several different medical situations. This includes deficiencies caused by certain gastrointestinal diseases, malignancy, and as an agent used in the Schilling test.


Q: Do I need to take Dodex at a specific time of day?

Official administration instructions detail the frequency (such as daily or monthly) and the route of the injection (Intramuscular or Subcutaneous). However, regulatory documents generally do not specify a particular time of day, such as morning or evening, for the injection.


Q: Can Dodex make existing conditions worse?

Yes, specific warnings are detailed in the official safety information. The medication is strictly contraindicated for individuals with early Leber’s disease due to the risk of severe optic nerve damage. Additionally, caution is required for patients with impaired kidney function because of the risk of aluminum accumulation from the injectable solution.


Q: Are there any long-term side effects that have been reported with Dodex?

Official precautions address the risk of aluminum accumulation to toxic levels when the injectable medicine is given over a prolonged period (long-term parenteral administration) to patients with already impaired kidney function.


Q: Are there any foods or drinks that should be avoided when taking Dodex?

Since Dodex is an injection, official documents state there are no known interactions between the injectable form of the drug and common foods or drinks.


Q: Can Dodex be taken with common pain relievers like Tylenol or Advil?

Official regulatory documents do not list specific interactions with common pain relievers like Acetaminophen (Tylenol) or NSAIDs (Advil/Ibuprofen). However, regulatory guidance highlights the importance of discussing all medications and supplements with a healthcare professional.


Q: What happens if a dose of Dodex is missed?

For patients who require lifelong treatment, such as those with pernicious anemia, the official label warns about the risks of inconsistent treatment. Failure to maintain the scheduled injection regimen may result in the return of anemia and the development of permanent neurological damage to the nerves of the spinal cord.


Q: Is it normal to feel a little tired after starting Dodex?

Official drug labels list specific, non-dosing related adverse effects such as malaise (a general feeling of discomfort) and dizziness. The medication is used to correct severe vitamin deficiency, but the regulatory label does not directly classify general tiredness or fatigue as a common side effect of the medicine itself.


Q: Is Dodex safe for older adults?

Regulatory documents do not contain specific clinical information regarding the relationship of age to the effects of this injection in geriatric patients. Regulatory documents note that caution is required when the medicine is used in patients with impaired kidney function.


Q: Are there any known issues with Dodex and driving?

According to official product information from one regulatory body, no specific effects on the ability to drive and use machines have been identified for this medication.


Q: Does Dodex have different brand names in other countries?

Yes, the active ingredient, Cyanocobalamin, is a generic compound that is marketed globally under many different brand names. Dodex is the trade name specific to this product information, but other regulatory documents reference names such as Cytamen.


Q: Can Dodex interact with herbal supplements?

Regulatory guidance emphasizes that a patient's healthcare professional should be informed about all prescription and non-prescription medicines, vitamins, and herbal products being consumed. This is due to the potential for substances to interfere with how the body handles the vitamin.


Q: What should I do if I think Dodex is not working for me?

The official label indicates the importance of re-evaluating the diagnosis or treatment regimen if the expected response in blood health (hematologic response) is not observed. Documents also suggest that folate metabolism should be investigated when the response is insufficient.


Q: What happens if I stop taking Dodex suddenly?

For patients with pernicious anemia, the official patient information warns that discontinuing the scheduled monthly injections will result in the return of anemia. This action is also associated with the development of incapacitating and irreversible damage to the nerves of the spinal cord.


Q: Do studies suggest Dodex is effective for children?

Regulatory dosage schemes for treating vitamin B12 deficiency are generally stated as being suitable for use in both adults and children. Supporting this, the FDA references the recommended daily intake amounts for children as set by the Food and Nutrition Board.


Q: Are there genetic factors that might affect how Dodex works?

The official contraindications list specifically excludes patients with early Leber's disease, which is a form of hereditary (genetic) optic nerve atrophy. This specific exclusion indicates that certain genetic predispositions can affect how the medicine is used.


Q: Is there a generic version of Dodex available?

Yes. Dodex is a brand name, but the active ingredient, Cyanocobalamin injection, is a widely used compound that is broadly available as a generic preparation.


Q: How does the body process or eliminate Dodex?

Pharmacokinetic data indicates that after injection, a significant portion of the dose is excreted in the urine within 24 hours. The compound is stored in the liver and undergoes a process known as enterohepatic recycling.


Q: Can Dodex be taken on an empty stomach?

As this is an injectable medication, administered directly into the muscle (IM) or under the skin (SC), its absorption is not influenced by the contents of the stomach. The instructions for use are independent of whether a patient has recently eaten.


Q: Does Dodex interact with alcohol?

Official documents note that heavy or chronic alcohol intake may impair the absorption of oral vitamin B12 from the digestive tract. However, alcohol does not affect the way the injectable form of the medicine works once it has been administered.


Q: Are there any common misuses of Dodex?

Regulatory documents caution healthcare providers against 'indiscriminate administration' of the drug. High doses are noted to have the potential to mask the true underlying diagnosis or produce an incomplete response in patients who may have a different, concurrent condition like folate deficiency.


Q: What if I experience a rare side effect mentioned in the official documents?

Regulatory guidance indicates that if a patient experiences any side effects, they should be discussed with their healthcare professional. Patients are also advised to report the event to the appropriate health authority, such as the FDA or local regulatory body.


Q: Is Dodex safe to take while breastfeeding?

Official patient information indicates that Vitamin B12 is secreted into human milk. While the compound is unlikely to cause harm to a nursing infant, the use of the medicine while breastfeeding is a factor that should be reviewed by a healthcare provider.

How should Dodex be stored and disposed of?

The storage and disposal of Dodex (Cyanocobalamin injection) must adhere strictly to official regulatory guidelines to maintain its stability and integrity.

Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature, generally 20 to 25 C (68 to 77 F). Do not freeze.
Protection The vial must be protected from light and stored in its original container.
Stability Multi-dose vials must be used within 30 days after the first puncture.
Safety Keep the medicine out of the reach of children.

Disposal Instructions

Expired or unused medicine should not be flushed down a toilet or poured down a drain. All used needles and sharps must be placed immediately in a designated, puncture-resistant disposal container. The filled sharps container should be discarded according to local rules for medical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dodex found in:

A-Z Index: